Allianz Asset Management
NVCR icon

Allianz Asset Management’s NovoCure NVCR Stock Holding History

Allianz Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
+148,411
New +$2.25M ﹤0.01% 1699
2024
Q2 		– Sell
-110,500
Closed -$1.73M – 2217
2024
Q1 		$1.73M Buy
110,500
+85,200
+337% +$1.25M ﹤0.01% 1232
2023
Q4 		$378K Buy
+25,300
New +$339K ﹤0.01% 1933
2023
Q3 		– Sell
-10,477
Closed -$435K – 2242
2023
Q2 		$435K Sell
10,477
-10,302
-50% -$640K ﹤0.01% 1771
2023
Q1 		$1.25M Buy
20,779
+3,488
+20% +$279K ﹤0.01% 1591
2022
Q4 		$1.27M Sell
17,291
-3,023
-15% -$227K ﹤0.01% 1434
2022
Q3 		$1.54M Sell
20,314
-43,415
-68% -$3.39M ﹤0.01% 1317
2022
Q2 		$4.43M Sell
63,729
-8,912
-12% -$671K ﹤0.01% 1144
2022
Q1 		$6.02M Sell
72,641
-76,339
-51% -$5.62M ﹤0.01% 1156
2021
Q4 		$11.2M Buy
148,980
+41,707
+39% +$4.19M 0.01% 953
2021
Q3 		$12.5M Sell
107,273
-84,359
-44% -$12.8M 0.01% 919
2021
Q2 		$42.5M Buy
191,632
+84,466
+79% +$16.4M 0.04% 433
2021
Q1 		$14.2M Buy
107,166
+17,931
+20% +$2.84M 0.01% 725
2020
Q4 		$15.4M Sell
89,235
-112,577
-56% -$15.4M 0.02% 702
2020
Q3 		$22.5M Sell
201,812
-47,780
-19% -$3.82M 0.03% 534
2020
Q2 		$14.8M Buy
249,592
+103,263
+71% +$6.79M 0.02% 740
2020
Q1 		$9.85M Sell
146,329
-169
-0.1% -$13.4K 0.01% 858
2019
Q4 		$12.3M Sell
146,498
-36,489
-20% -$2.95M 0.01% 1016
2019
Q3 		$13.6M Sell
182,987
-52,685
-22% -$4.21M 0.01% 952
2019
Q2 		$14.9M Sell
235,672
-113,395
-32% -$5.75M 0.01% 959
2019
Q1 		$16.8M Sell
349,067
-93,820
-21% -$4.52M 0.02% 839
2018
Q4 		$14.8M Sell
442,887
-137,450
-24% -$5.03M 0.02% 885
2018
Q3 		$30.4M Sell
580,337
-118,386
-17% -$4.71M 0.03% 646
2018
Q2 		$21.9M Sell
698,723
-229,302
-25% -$6.38M 0.02% 831
2018
Q1 		$20.2M Buy
928,025
+395,316
+74% +$8.5M 0.02% 878
2017
Q4 		$10.8M Buy
+532,709
New +$10.3M 0.01% 1282

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Allianz Asset Management's NVCR Position: Q2 2026 in Review

Allianz Asset Management opened a new position in NovoCure (NVCR) in Q2 2026: 148,411 shares worth $2.25M. The stake represents ﹤0.01% of the portfolio and ranks #1699 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in NVCR as recently as Q1 2024.

Allianz Asset Management first reported a position in NVCR in Q4 2017 and has held it in 26 quarters since. The position peaked at $42.5M in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Allianz Asset Management held 148,411 shares of NovoCure worth $2.25M as of Q2 2026.
  • NovoCure was a new Allianz Asset Management position in Q2 2026.
  • NovoCure made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1699 holding.
  • Allianz Asset Management first reported a position in NovoCure in Q4 2017 and has held it in 26 quarters since.
  • Allianz Asset Management's NovoCure position peaked at $42.5M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.